O'Shaughnessy Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.9M Buy
320,027
+19,949
+7% +$3.06M 0.25% 86
2025
Q4
$41.4M Buy
300,078
+14,273
+5% +$1.87M 0.23% 88
2025
Q3
$36.7M Buy
285,805
+20,820
+8% +$2.54M 0.22% 89
2025
Q2
$32.1M Buy
264,985
+9,388
+4% +$1.06M 0.22% 90
2025
Q1
$28.5M Buy
255,597
+40,152
+19% +$4.27M 0.23% 96
2024
Q4
$21M Sell
215,445
-17,917
-8% -$1.91M 0.18% 121
2024
Q3
$27.1M Buy
233,362
+41,859
+22% +$4.75M 0.24% 82
2024
Q2
$20.4M Buy
191,503
+10,739
+6% +$1.08M 0.21% 105
2024
Q1
$17.5M Buy
180,764
+11,080
+7% +$1.14M 0.19% 114
2023
Q4
$17.1M Buy
169,684
+7,813
+5% +$754K 0.23% 103
2023
Q3
$16.5M Buy
161,871
+16,882
+12% +$1.71M 0.25% 109
2023
Q2
$14.6M Buy
144,989
+21,757
+18% +$2.18M 0.22% 120
2023
Q1
$11.3M Sell
123,232
-6,696
-5% -$585K 0.18% 135
2022
Q4
$11.8M Buy
129,928
+65,943
+103% +$5.55M 0.19% 142
2022
Q3
$4.86M Sell
63,985
-2,497
-4% -$207K 0.09% 237
2022
Q2
$5.62M Buy
66,482
+14,666
+28% +$1.29M 0.1% 213
2022
Q1
$4.55M Buy
51,816
+20,301
+64% +$1.76M 0.08% 264
2021
Q4
$2.76M Buy
31,515
+7,780
+33% +$646K 0.05% 316
2021
Q3
$1.94M Sell
23,735
-7,681
-24% -$691K 0.04% 321
2021
Q2
$2.87M Buy
31,416
+3,550
+13% +$316K 0.06% 257
2021
Q1
$2.38M Buy
27,866
+2,275
+9% +$204K 0.05% 244
2020
Q4
$2.42M Buy
25,591
+405
+2% +$35.4K 0.07% 185
2020
Q3
$2.19M Sell
25,186
-3,703
-13% -$321K 0.07% 174
2020
Q2
$2.52M Buy
28,889
+14,981
+108% +$1.29M 0.08% 146
2020
Q1
$1.15M Sell
13,908
-1,768
-11% -$158K 0.04% 190
2019
Q4
$1.48M Buy
15,676
+8,894
+131% +$798K 0.03% 218
2019
Q3
$589K Buy
6,782
+1,070
+19% +$96.1K 0.01% 352
2019
Q2
$522K Buy
5,712
+691
+14% +$58.5K 0.01% 358
2019
Q1
$433K Sell
5,021
-165
-3% -$13.2K 0.01% 385
2018
Q4
$399K Buy
5,186
+4,754
+1,100% +$370K 0.01% 368
2018
Q3
$33K Buy
432
+36
+9% +$2.66K ﹤0.01% 738
2018
Q2
$27K Buy
396
+92
+30% +$6.35K ﹤0.01% 747
2018
Q1
$22K Buy
+304
New +$23.1K ﹤0.01% 766

Other funds holding NVS